Conformational movement of the C-terminal ␣7 helix in the integrin inserted (I) domain, a major ligand-binding domain that adopts an ␣͞␤ Rossmann fold, has been proposed to allosterically regulate ligand-binding activity. Disulfide bonds were engineered here to reversibly lock the position of the ␣7 helix in one of two alternative conformations seen in crystal structures, termed open and closed. Our results show that pairs of residues with C␤ atoms farther apart than optimal for disulfide bond stereochemistry can be successfully replaced by cysteine, suggesting that backbone movement accommodates disulfide formation. We also find more success with substituting partially exposed than buried residues. Disulfides stabilizing the open conformation resulted in constitutively active ␣M␤2 heterodimers and isolated ␣M inserted domains, which were reverted to an inactive form by dithiothreitol reduction. By contrast, a disulfide stabilizing the closed conformation resulted in inactive ␣M␤2 that was resistant to activation but became activatable after dithiothreitol treatment. The transition from the closed to the open conformation has been shown to regulate affinity for ligand and suggested to function in inside-out signaling to the I domain from the rest of the receptor. Structure-oriented mutagenesis approaches have been taken to stabilize one conformation over another and to address the functional significance of alternative conformations of the ␣M I domain (7, 8) . One approach used the computational algorithm ORBIT to stabilize ␣M I domains in open or closed conformations by finding mutations in the hydrophobic core that minimize the energy of either the open or closed conformation (7). The designed open I domains, which contained 8-13 mutations in the hydrophobic core, showed increased binding to ligand both in intact ␣M␤2 and when expressed as isolated I domains on the cell surface. By contrast, the designed closed I domain was inactive. Another study mutated Ile-316, which is in the last one-half of the C-terminal ␣7 helix of the ␣M I domain and is packed in a hydrophobic pocket at the bottom of the I domain in the closed but not in the open conformation (8).
Conformational movement of the C-terminal ␣7 helix in the integrin inserted (I) domain, a major ligand-binding domain that adopts an ␣͞␤ Rossmann fold, has been proposed to allosterically regulate ligand-binding activity. Disulfide bonds were engineered here to reversibly lock the position of the ␣7 helix in one of two alternative conformations seen in crystal structures, termed open and closed. Our results show that pairs of residues with C␤ atoms farther apart than optimal for disulfide bond stereochemistry can be successfully replaced by cysteine, suggesting that backbone movement accommodates disulfide formation. We also find more success with substituting partially exposed than buried residues. Disulfides stabilizing the open conformation resulted in constitutively active ␣M␤2 heterodimers and isolated ␣M inserted domains, which were reverted to an inactive form by dithiothreitol reduction. By contrast, a disulfide stabilizing the closed conformation resulted in inactive ␣M␤2 that was resistant to activation but became activatable after dithiothreitol treatment.
cell adhesion ͉ protein design ͉ CD11b ͉ Mac-1 ͉ VWA domain N ine of 18 integrin ␣ subunits in vertebrates contain an inserted (I) domain of Ϸ200 residues that is implicated in binding to protein ligands (1) (2) (3) . The I domain adopts a VWA domain ␣͞␤ fold with a central hydrophobic ␤-sheet surrounded by ␣-helices. The ''top'' face of the domain is implicated in ligand binding and contains a metal ion-dependent adhesion site (MIDAS) with a bound Mg 2ϩ ion. I domain structures have revealed two different conformations, the liganded open conformation and the unliganded closed conformation (4, 5) . Ligation of the MIDAS metal ion by ligand or a ligand-mimetic lattice contact is associated with a rearrangement of metal ion coordination at the MIDAS and a linked 10-Å movement of the C-terminal helix down the body of the domain (5, 6) . The transition from the closed to the open conformation upon ligand binding is thought to convey outside-in signaling from the I domain to the rest of the receptor by means of the downward shift of the C-terminal ␣7 helix of the I domain.
The transition from the closed to the open conformation has been shown to regulate affinity for ligand and suggested to function in inside-out signaling to the I domain from the rest of the receptor. Structure-oriented mutagenesis approaches have been taken to stabilize one conformation over another and to address the functional significance of alternative conformations of the ␣M I domain (7, 8) . One approach used the computational algorithm ORBIT to stabilize ␣M I domains in open or closed conformations by finding mutations in the hydrophobic core that minimize the energy of either the open or closed conformation (7) . The designed open I domains, which contained 8-13 mutations in the hydrophobic core, showed increased binding to ligand both in intact ␣M␤2 and when expressed as isolated I domains on the cell surface. By contrast, the designed closed I domain was inactive. Another study mutated Ile-316, which is in the last one-half of the C-terminal ␣7 helix of the ␣M I domain and is packed in a hydrophobic pocket at the bottom of the I domain in the closed but not in the open conformation (8) .
Packing of Ile-316 in the pocket was predicted to favor the closed conformation. Mutation of the isoleucine to glycine resulted in increased ligand-binding affinity.
Here we test the effect on ligand-binding activity of reversibly locking the ␣M I domain in alternative conformations with disulfide bonds. Furthermore, we compare residues mutated to cysteine for side-chain burial and pairwise distance to determine the factors that influence the ability to successfully engineer conformation-specific disulfide bonds. Previously, disulfide bonds were engineered that lock the ␣L I domain in either the open or the closed conformation (9, 10) . Only one disulfide bond was tested to stabilize each conformation. Each pair of residues mutated to cysteine had C␤ atom distances ideal for disulfide formation. Each mutation stabilized the desired conformational state; however, whereas the activating effect of the open mutant was reversible with reduction (10), the deactivating effect of the closed mutant was not (unpublished data). We find that introduction of a pair of cysteines equivalent to those used in the open mutant of ␣L is disruptive and does not activate the ␣M I domain. Nonetheless, we are able to find other pairs of activating and deactivating cysteine substitutions and provide evidence that their functional effects are reversed by disulfide reduction. Our results show that the search space for finding conformationspecific disulfide bonds can be expanded markedly beyond optimal C␤-C␤ atom distances into a range in which backbone movement is required to accommodate disulfide bond formation. Our results also suggest that boundary residues are favored over buried residues for disulfide-forming cysteine substitutions that have predictable effects on affinity. Furthermore, we engineer disulfide bonds that bridge not only from ␣7 to ␤6 but also from ␣7 to ␣1. We provide a demonstration of reversibly locking an I domain in the closed conformation and a demonstration that the ␣M I domain can be reversibly locked in the open conformation. The results generalize and markedly expand the scope for engineering conformation-specific disulfide bonds.
Methods
cDNA Construction and Expression. Overlap-extension PCR (11) was used to generate cysteine-substitution mutations in the ␣M I domain. Wild-type human intact ␣M (12) and wild-type ␣M I domain platelet-derived growth factor receptor cDNA constructs (7) in vector pcDNA 3.1͞hygro were used as templates. Transient transfection of 293T and stable transfection of K562 cells were as described (7, 13) .
Flow Cytometry and Adhesion Assay. Immunofluorescence flow cytometry using indirect staining with fluoresceinated antimouse IgG was as described (7, 13) . Cell adhesion to immobilized iC3b, a cleaved form of the complement component C3, in flat 96-well plates was as described (7, 13) .
Results

Prediction of Disulfide Bonds to Stabilize the ␣M I Domain in Either the
Open or the Closed Conformation. Regions of the ␣M I domain that differ between the open and closed conformations (4, 5) were visually inspected by using molecular graphics for positions in which pairs of cysteines could be introduced that would form disulfides that would favor one conformation over the other. Thus, the region of the conformationally mobile C-terminal ␣7 helix and the preceding loop were examined for positions in which one cysteine could be introduced, and structurally adjacent regions were searched for positions where a second cysteine could be introduced that would form a disulfide. Pairs of residues whose side chains face toward one another were chosen. The distance between the C␤ atoms of each of these residue pairs was measured in both the open and the closed conformation (Table  1) . We found three pairs of cysteine substitutions where the C␤-C␤ distances were more favorable for disulfide formation in the open conformation than in the closed conformation: F297C͞ A304C, Q163C͞Q309C, and D294C͞Q311C (Table 1 and Fig. 1 A-C), and we found one pair of cysteine substitutions where the C␤-C␤ distances were more favorable for disulfide formation in the closed conformation than in the open conformation: Q163C͞ R313C (Table 1 and Fig. 1D ). Notably, all substitutions except F297C͞A304C involved C␤-C␤ distances larger than the optimal distance of 3.4-4.2 Å (14) ( Table 1 ) and thus would require backbone readjustments to accommodate disulfide formation.
Functional Analysis of Locked Open Mutants in Intact ␣M␤2 Heterodimers. ␣M␤2 heterodimers containing wild-type or mutant I domains were transiently expressed in 293T cells, in which even wild-type ␣M␤2 has basal activity for ligand binding (7, 13) . Transfectants were tested for adhesion to iC3b-coated substrates. All but two of the single-cysteine substitutions bound ligand as well as did wild type. The exceptions were mutations F297C and A304C, which partially impaired ligand binding ( Fig.  2A) . Of the three double mutations designed to stabilize the open conformation of the I domain, Q163C͞Q309C and D294C͞ (28) . Q311C bound ligand as well as did wild type (Fig. 2 A) . By contrast, F297C͞A304C was less active than wild type (Fig. 2 A) .
To further characterize the mutants, stable transfectants were made in K562 cells, in which wild-type ␣M␤2 shows little basal ligand-binding activity (7, 13) . ␣M␤2 containing the wild-type I domain showed little binding to ligand (Fig. 2B ) and little expression of the CBRM1͞5 activation epitope (15) (Fig. 2C) . By contrast, ␣M␤2 containing open mutations Q163C͞Q309C and D294C͞Q311C showed strong binding to ligand and marked expression of the CBRM1͞5 epitope (Fig. 2 B and C) . By contrast, the F297C͞A304C mutant was inactive, correlating with the decreased activity of the individual F297C and A304C and double F297C͞A304C mutations in 293T cells.
Reduction with DTT was used to reverse the engineered disulfide bonds. DTT generally augments adhesiveness by wildtype integrins, probably by reducing certain disulfide bonds that help restrain integrins in a resting conformation (10, 16, 17) . Adhesion through wild-type ␣M␤2 was increased by DTT (Fig.  2B) . However, DTT treatment did not increase adhesion through ␣M␤2 to the same level as achieved by activation with CBR LFA-1͞2 mAb, or by the Q163C͞Q309C or D294C͞Q311C mutations in the absence of DTT (Fig. 2B) . DTT treatment of the open Q163C͞Q309C and D294C͞Q311C mutants reduced adhesion, to the same level as DTT-treated wild-type ␣M␤2 transfectants. This result provides functional evidence that reversal of the introduced disulfide bond in these mutants abolishes its enhancement of adhesiveness.
Functional Analysis of Locked Closed I Domains in Intact ␣M␤2
Heterodimers. ␣M␤2 containing the closed Q163C͞R313C mutation did not bind to ligand, whereas wild type as well as the corresponding Q163C and R313C single-cysteine substitutions bound ligand strongly in 293T transfectants (Fig. 2 A) . Even after activation by CBR LFA-1͞2 mAb, ␣M␤2 containing the closed Q163C͞R313C mutation failed to bind to ligand (Fig. 3A) . By contrast, DTT treatment of Q163C͞R313C ␣M␤2 transfectants restored ligand-binding activity, and this mutant became susceptible to activation by CBR LFA-1͞2 mAb (Fig. 3A) . All mutants studied here bound CBR LFA-1͞2 mAb similarly to wild type, whether or not treated with DTT (not shown). This result provides functional evidence that a disulfide formed in the Q163͞R313C mutant restrained ␣M␤2 in an inactive conformation.
Consistent with these results, the expression of the CBRM1͞5 activation epitope in ␣M␤2 containing the closed Q163C͞ R313C mutation was lower than that in wild-type ␣M␤2 and was not increased by activation with CBR LFA-1͞2 mAb (Fig. 3B) . However, after DTT treatment, CBRM1͞5 epitope expression was increased and was further enhanced by CBR LFA-1͞2 mAb (Fig. 3B ).
Functional Analysis of Mutant I Domains in Isolation. To examine ligand binding by the mutant I domains in isolation from other integrin domains, ␣M I domains containing the open Q163C͞
Q309C, open D294C͞Q311C, and closed Q163C͞R313C mutations were expressed on K562 cells after fusion to an N-terminal signal sequence and a C-terminal platelet-derived growth factor receptor transmembrane domain (7) . Wild-type and closed mutant Q163C͞R313C isolated I domains showed essentially no binding to iC3b (Fig. 4) . By contrast, open mutant Q163͞Q309C and D294C͞Q311C isolated I domains expressed at the same level on the cell surface gave robust binding to iC3b (Fig. 4) .
Binding of the open Q163C͞Q309C and D294C͞Q311C isolated ␣M I domain mutants was equivalent to that of the isolated ␣M I domain mutant ido1r, which is stabilized in the open conformation by hydrophobic core substitutions (7) (data not shown). Complete inhibition by CBRM1͞5 (Fig. 4A) or EDTA (Fig. 4B ) shows that ligand binding is specific to the ␣M I domain MIDAS. Binding was equivalent in Mg 2ϩ and Mn 2ϩ (Fig. 4B) . DTT treatment was used to confirm that a disulfide bond was required for the ligand-binding activity of the open mutant isolated I domains. Binding of open mutant Q163C͞Q309C and D294C͞Q311C isolated I domains to iC3b was abolished after DTT treatment (Fig. 4A) . The wild-type isolated I domain, which contains no disulfide bond, failed to bind to ligand regardless of DTT treatment. These data functionally confirmed that the pairs of cysteines introduced into the Q163C͞Q309C and D294C͞Q311 mutants formed disulfide bridges that constrained the I domains in the open, high-affinity, conformation and that after reduction the conformation shifted to the closed, low-affinity state.
Discussion
We have demonstrated that the ␣M I domain can be reversibly stabilized in either the open or the closed conformation by engineered disulfide bonds that link the ␣7 helix to neighboring regions in the I domain structure. Two of three mutants designed to stabilize the open, high-affinity conformation of the ␣M I domain were successful. They greatly increased ligand-binding activity in both ␣M␤2 heterodimers and isolated ␣M I domains expressed on the cell surface. Furthermore, disulfide reduction decreased ligand binding to wild-type levels. These data are consistent with previous findings that for the wild-type ␣M I domain the closed conformation is energetically favored over the open conformation (7, 8) . Contrasting results were obtained with a mutation designed to introduce a disulfide that would stabilize the ␣M I domain in the closed conformation. This mutant ␣M␤2 was constitutively inactive in 293T cells, in which wild-type ␣M␤2 is constitutively active. ␣M␤2 containing this locked closed I domain was resistant to activation, but after DTT reduction became competent for ligand binding and became susceptible to further activation with an activating mAb. These results suggest that activation signals to the I domain MIDAS are transmitted by pull-down of the C-terminal ␣7 helix, which was blocked by constraint with the disulfide bridge in the locked closed I domain, and that communication through this helix was restored after release of the constraint by DTT. Thus, mutations that reversibly inactivate I domains have been demonstrated. Interestingly, small molecule antagonists of ␣L␤2 have been described that have a similar mechanism of action. These bind in a pocket beneath the ␣7 helix, interfere with its downward movement, and allosterically block activation of ligand binding (18) (19) (20) .
Comparisons among the different double-cysteine mutations tested here reveal some principles that may be generally useful in future designs of conformation-specific disulfide bonds. The ideal separation for cysteine C␤ carbons for formation of a disulfide bond is reported to be 3.41-4.25 Å (14) . Nonetheless, the two successful open mutants, Q163C͞Q309C and D294C͞ Q311C, spanned larger C␤ distances (6.4 and 7.1 Å), as did the closed mutant Q163C͞R313C (5.2 Å) ( Table 1) . Backbone movement must therefore have occurred to accommodate disulfide formation. The residues 309, 311, and 313 are in the most C-terminal half of the ␣7 helix. Residue 163 is the last residue in the ␣1 helix, and residue 294 is in a short ␣-helical turn preceding the ␤6 strand. These ␣-helical segments would be more permissive than ␤-strands for rigid body movements as well as localized backbone deformation. Because some backbone movements appear to have occurred, it is impressive that the mutants favored the predicted conformations, especially Q163C͞Q309C, in which the two C␤ atoms were only 0.8 Å less distant in the open conformation than in the closed conformation (Table 1) .
We believe that the failure of the F297C͞A304C mutation to stabilize the open conformation is due to disruption of the hydrophobic core. All of the successful designs involved mutations of residues that are more exposed than either F297 or A304 ( Table 1 ). The individual substitutions F297C and A304C were deleterious for ligand binding, in contrast to all of the other individual substitutions. This result suggests that they were individually destabilizing, and the results with the double substitution suggest that in combination they are even more destabilizing. Treatment with DTT did not reverse destabilization by the F297C͞A304C mutation, suggesting the deleterious effect is due to disruption of packing rather than disulfide bond formation. Previous work has shown that despite some notable successes, it is difficult to engineer in disulfide bonds that increase the stability of proteins because of disruption of packing interactions and the stereospecific requirements of disulfide bonds (21) (22) (23) . In ␣L, the residues equivalent to F297 and A304 are each lysine, implying a markedly different packing environment.
This implication is consistent with the finding that replacement of these lysines by cysteines in ␣L results in a disulfide bond that dramatically stabilizes the open, ligand-binding, conformation (9, 10) .
The residues with which design was successful are all boundary residues, i.e., intermediate between hydrophobic core and fully surface-exposed residues. The solvent accessibility of these residues ranges from 18% to 50% (mean ϭ 32%) in the conformation favored by the design, in contrast to Phe-304 and Ala-297, which are 10% and 0% exposed. Boundary residues appear favorable for mutation to disulfide-forming cysteines because their more loosely packed environment can adjust to the stereochemical requirements of the disulfide-bridged cysteine side chains, while at the same time providing partial burial of these largely hydrophobic moieties.
Disulfide bonds have previously been used to study conformational movements within proteins or between subunits, e.g., see refs. 24-26. Current programs used to find pairs of residues that can be mutated to cysteine to form disulfide bonds, e.g. ref.
14, select only those residues with optimal C␣ and C␤ distances and stereochemistry. Ironically, none of the successful designs here meet these criteria, whereas the one unsuccessful one does. Our results thus show that the search space for conformationspecific disulfide bond-forming mutations can be expanded to pairs of residues with C␤ atom distances of up to at least 7.1 Å and at the same time suggest that partially buried residues with nonoptimal C␤ atom distances may yield better success than fully buried residues with optimal C␤ distances. The same principles have been used in parallel to successfully introduce multiple conformation-specific disulfide bonds in the ␣L I domain (27) . Therefore, it seems highly likely that stabilizing the open, high-affinity, conformation with disulfide bonds can be extended to all nine vertebrate integrin ␣ subunits that contain I domains, and possibly to the I-like domain present in all integrin ␤ subunits as well. Furthermore, extension to other allosterically regulated proteins that can be expressed in nonreducing environments seems promising.
